3D-reconstruction

2

Review clinical trials related to 3D-reconstruction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Application of 3D Reconstruction for Preoperative Strategy of Locally Advanced Colon Cancer

The aim of this study is to assess the usefulness of a mathematical model of three-dimensional image process and reconstuction (3D-IPR) as a surgical planner in locally advanced colon cancer. In addition to comparing the diagnostic accuracy of this planner with that of the CT regarding the infiltration of neighbouring structures.

Participants needed: 168
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fundació d'investigació Sanitària de les Illes BalearsUpdated: Apr 21, 2026
Eligibility criteria

Patients of both sexes, aged ≥18 years. [+3]

Suspected carcinomatosis on preoperative CT or intraoperative finding [+2]

Status: Not yet recruiting

3D Liver Volumetry

The study aims to improve preoperative evaluation of liver resection volume in patients undergoing major hepatectomies. Accurate prediction of the planned resection and the future liver remnant (FLR) is critical to minimize the risk of postoperative liver failure, which is associated with increased morbidity and mortality. Conventional imaging-based volumetry may have limited accuracy. This study investigates the use of individualized 3D liver models combined to enhance visualization and volumetric analysis of liver anatomy and resection boundaries. Patients are recruited in the liver outpatient clinic and, upon consent, preoperative 3D models are created using Medics 3D. During surgery, the planned resection is guided by the individualized 3D models. Postoperatively, the resected specimen undergoes CT-based volumetry to compare the predicted resection volume from the 3D model with the actual volume. Routine postoperative follow-up is conducted. The study aims to optimize surgical planning, enhance the accuracy of future liver remnant prediction.

Participants needed: 25
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medical University of GrazUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

Adult patients (≥18 years) undergoing open or minimally invasive major liver res...

Patients unable to provide informed consent will be excluded. [+2]